Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Director's Dealing 2009

Dec 13, 2009

65285_rns_2009-12-13_248d68d3-f41a-4252-bdc0-b8bc890871b6.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Safety Medical Products Limited ABN 26 007 817 192

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director John Riemelmoser
Date of last notice 4 June 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
N/A
Date of change 11 December 2009
No. of securities held prior to change Ordinary Shares
10,801,900
SFPOA $1 Options (expiry 31-12-10)
5,400,950
Unsecured Convertible Notes maturing on 31
July 2010
3,000
Class Ordinary Shares
Number acquired 333,333
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$0.045 per share
No. of securities held after change Ordinary Shares – 11,135,233
SFPOA $1 Options (expiry 31-12-10)
5,400,950
Unsecured Convertible Notes expiring 31
July 2010
3,000
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Issue of 333,333 Ordinary Shares under the
Share Purchase Plan announced on 28
October 2009.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Safety Medical Products Limited ABN 26 007 817 192

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr John Darley
Date of last notice 4 June 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest (a) Direct
(b) Indirect
(c) Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
(b)Mrs Mathilda Darley (wife of Mr John
Darley)
(c) Mrs Mathilda Darley (wife of Mr John
Darley)
Date of change 11 December 2009
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change (a) Mr John Darley
Ordinary Shares
557,382
SFPOA $1 Options (expiry 31-12-10)
278,691
Unsecured Convertible Notes
2,000 maturity date 31 July 2010
(b) Mrs Mathilda Darley
Ordinary Shares
89,882
SFPOA $1 Options (expiry 31-12-10)
44,941
(c) Mrs Mathilda Darley & Mrs Kim
Duffield
Ordinary Shares
23,882
SFPOA $1 Options (expiry 31-12-10)
11,941
Class Ordinary Shares
Number acquired 333,333
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$0.045
No. of securities held after change (a) Mr John Darley
Ordinary Shares
557,382
SFPOA $1 Options (expiry 31-12-10)
278,691
Unsecured Convertible Notes
2,000 maturity date 31 July 2010
(b) Mrs Mathilda Darley
Ordinary Shares
423,215
SFPOA $1 Options (expiry 31-12-10)
44,941
(c) Mrs Mathilda Darley & Mrs Kim
Duffield
Ordinary Shares
23,882
SFPOA $1 Options (expiry 31-12-10)
11,941
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Issue of 333,333 Ordinary Shares to Mrs
Mathilda Darley under the Share Purchase
Plan announced on 28 October 2009.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002